Literature DB >> 8627761

Astrovirus ribosomal frameshifting in an infection-transfection transient expression system.

T L Lewis1, S M Matsui.   

Abstract

Different regions of the human astrovirus frameshift signal were cloned into the rhesus rotavirus VP4 gene and evaluated in an infection-transfection transient expression cell culture system. BHK-21 cells, infected with a vaccinia virus that expresses T7 RNA polymerase (vTF7-3), were transfected with the various astrovirus-VP4 constructs. All constructs were driven by a T7 promoter and contained an internal ribosome entry site. Frameshifted and nonframeshifted protein products were immunoprecipitated with VP4 amino- and carboxy-terminal-specific monoclonal antibodies, and their ratios were determined by PhosphorImager analysis. The efficiency of frameshifting was 25 to 28%, significantly greater than the 5 to 7% efficiency reported previously in a cell-free translation system. Coupling of transcription and translation in a cell-free system yielded frameshifting efficiencies threefold greater than that of the uncoupled in vitro system. The presence of the shifty heptamer was an absolute requirement for frameshifting in both cell-free and intact-cell systems, while deletion of the potential downstream pseudoknot region did not affect the efficiency of frameshifting.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627761      PMCID: PMC190144     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting.

Authors:  T Jacks; H E Varmus
Journal:  Science       Date:  1985-12-13       Impact factor: 47.728

3.  Characterization of ribosomal frameshifting in HIV-1 gag-pol expression.

Authors:  T Jacks; M D Power; F R Masiarz; P A Luciw; P J Barr; H E Varmus
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

Review 4.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

5.  The complete sequence of a human astrovirus.

Authors:  M M Willcocks; T D Brown; C R Madeley; M J Carter
Journal:  J Gen Virol       Date:  1994-07       Impact factor: 3.891

6.  Letter: Viruses in infantile gastroenteritis.

Authors:  C R Madeley; B P Cosgrove
Journal:  Lancet       Date:  1975-07-19       Impact factor: 79.321

7.  Astroviruses: human and animal.

Authors:  J B Kurtz; T W Lee
Journal:  Ciba Found Symp       Date:  1987

8.  Antigenic mapping of the surface proteins of rhesus rotavirus.

Authors:  R D Shaw; P T Vo; P A Offit; B S Coulson; H B Greenberg
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

9.  Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region.

Authors:  T Jacks; H D Madhani; F R Masiarz; H E Varmus
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

10.  An efficient ribosomal frame-shifting signal in the polymerase-encoding region of the coronavirus IBV.

Authors:  I Brierley; M E Boursnell; M M Binns; B Bilimoria; V C Blok; T D Brown; S C Inglis
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  23 in total

1.  Proteolytic processing of a serotype 8 human astrovirus ORF2 polyprotein.

Authors:  Ernesto Méndez; Teresa Fernández-Luna; Susana López; Martha Méndez-Toss; Carlos F Arias
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

2.  Protein products of the open reading frames encoding nonstructural proteins of human astrovirus serotype 8.

Authors:  Ernesto Méndez; M P Elizabeth Salas-Ocampo; María Elena Munguía; Carlos F Arias
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

3.  Detection of a novel astrovirus in brain tissue of mink suffering from shaking mink syndrome by use of viral metagenomics.

Authors:  Anne-Lie Blomström; Frederik Widén; Anne-Sofie Hammer; Sándor Belák; Mikael Berg
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

4.  C-terminal nsP1a protein of human astrovirus colocalizes with the endoplasmic reticulum and viral RNA.

Authors:  Susana Guix; Santiago Caballero; Albert Bosch; Rosa M Pintó
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 5.  Identification of structural domains involved in astrovirus capsid biology.

Authors:  Neel K Krishna
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

6.  Crystal structure of the human astrovirus capsid spike.

Authors:  Jinhui Dong; Liping Dong; Ernesto Méndez; Yizhi Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

7.  Propagation of Astrovirus VA1, a Neurotropic Human Astrovirus, in Cell Culture.

Authors:  Andrew B Janowski; Irma K Bauer; Lori R Holtz; David Wang
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

8.  Complete genome sequence of human astrovirus genotype 6.

Authors:  Li Guo; Richard Gonzalez; Wei Wang; Yongjun Li; Gláucia Paranhos-Baccalà; Guy Vernet; Jianwei Wang
Journal:  Virol J       Date:  2010-02-08       Impact factor: 4.099

Review 9.  Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use.

Authors:  John F Atkins; Gary Loughran; Pramod R Bhatt; Andrew E Firth; Pavel V Baranov
Journal:  Nucleic Acids Res       Date:  2016-07-19       Impact factor: 16.971

10.  Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent.

Authors:  Ping-Kun Hsieh; Shin C Chang; Chu-Chun Huang; Ting-Ting Lee; Ching-Wen Hsiao; Yi-Hen Kou; I-Yin Chen; Chung-Ke Chang; Tai-Huang Huang; Ming-Fu Chang
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.